Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Recursion Pharmaceuticals is transforming drug discovery with AI-driven RecursionOS, slashing costs and boosting development ...

Reliance Industries Ltd's investments in artificial intelligence (AI) and new energy infrastructure are projected to drive a $50 billion increase in its market value.

SandboxAQ, an AI startup spun out of Google and backed by NVIDIA, has released a massive new dataset it hopes will revolutionize early-stage drug discovery. On Wednesday, the company unveiled the ...

SandboxAQ releases over 5 million AI-generated protein-drug structures to accelerate drug discovery and rival lab testing.

VAST Data, the AI Operating System company, announced today that it is delivering a complete data and compute platform that ...

Constellation Research found R 'Ray' Wang breaks down Micron's anticipated earnings report and his expectations for Nvidia's ...

Tim Knight contrasts the 2000 internet bubble with today's speculative assets like Bitcoin, as the markets face a downturn ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

In this 2025 insight release, Weiss Ratings highlights the rise of autonomous robotics as the next frontier in artificial ...

From call centres to back-office systems, telcos are navigating the shift from predictive ML to generative AI, balancing ...

Microsoft has spent years designing its own artificial intelligence chips, in part to reduce its dependence on Nvidia. It isn ...